Products and withdrawal from the market Sibutramine was approved in 1999 and was commercially available in many countries in 10- and 15-mg capsule form (Reductil, Abbott AG). On March 29, 2010, Abbott AG, in consultation with Swissmedic, informed the public that the marketing authorization had been suspended. Since then, sibutramine may no longer be prescribed … Sibutramine
Products Amfepramone is commercially available in the form of capsules (e.g., Regenon). The drug is not registered in many countries. Structure and properties Amfepramone (C 13 H 19 NO, M r = 205.3 g/mol) is structurally related to cathinone. Effects Amfepramone (ATC A08AA03) has indirect sympathomimetic, appetite suppressant, and antiadipose properties. The effects are due … Amfepramone
Products Aminorex was approved in many countries in 1965 and withdrawn from the market in 1972 due to adverse effects (Menocil). Structure and properties Aminorex (C9H10N2O, Mr = 162.2 g/mol) is a dihydrooxazolamine structurally related to amphetamines. Effects Aminorex has appetite suppressant properties. The effects are due to the release of catecholamines. Indications For the … Aminorex
